MedWatch

Advanced Bionics Denmark increases bottom line almost tenfold

New products and cost reductions boosted the Sonova-owned provider of cochlear implant systems in its recently concluded financial year.

Photo: Doug Finger/AP/Ritzau Scanpix

Hearing group Advanced Bionics’s Danish division has increased its sales, particularly of new products, increasing its bottom line almost tenfold in financial 2021/2022 compared to the preceding year, according to its recently released annual report.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs